---
title: Process Development CDMOs in Canada
path: /services/process-development/canada
companies_count: 14
---

# Process Development CDMOs in Canada

14 published CDMOs match Process Development in Canada.

Locations in this set include Canada, United States, Bangladesh, France, India, and Italy.

Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Biologics (Monoclonal Antibodies), Gene Therapy, and mRNA.

## Matching companies

- [ARSI Canada Inc](/companies/arsicanada)
  - ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.
- [BioVectra](/companies/biovectra)
  - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.
- [Burrard Pharmaceuticals](/companies/burrardpharma)
  - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005.
- [Clearsynth](/companies/clearsynth)
  - Clearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.
- [Dalton Pharma Services](/companies/dalton)
  - Health Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges.
- [Delpharm](/companies/delpharm)
  - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
- [Galenvs Sciences](/companies/galenvs-sciences)
  - Galenvs makes modified, specialty oligonucleotides for drug and gene-therapy programs, from proof of concept to pilot scale, under an ISO 9001:2015 certified quality system.
- [HAARES ChemTech Inc.](/companies/haareschemtech)
  - HAARES ChemTech provides custom synthesis and contract R&D for complex organic molecules from Edmonton, Canada. Its PhD-level chemists work from milligram to multi-kilogram scale, and the company also offers process development and intermediate manufacture.
- [Halo Pharma](/companies/halo-pharma)
  - Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.
- [Medicap Laboratories](/companies/medicaplab)
  - Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products.
- [National Resilience](/companies/resilience)
  - End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.
- [Northern RNA](/companies/northernrna)
  - Northern RNA is a Calgary, Alberta-based manufacturer of nucleic acids, offering plasmid DNA and mRNA production, chemical manufacturing, and lipid and LNP formulation services. The company also provides analytical and stability testing and development services.
- [Omniabio](/companies/omniabio)
  - OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
- [Sussex Research Laboratories Inc.](/companies/sussex-research)
  - Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.